ACCP White Paper Consolidates Evidence for Inpatient Clinical Pharmacy Value
This white paper aggregates economic, clinical, and humanistic evidence supporting inpatient clinical pharmacy services and provides advocacy tools pharmacists can use to justify and expand staffing models.
clinical pharmacy servicesinpatient pharmacyantimicrobial stewardshiptransitions of carecritical care pharmacymedication reconciliationhealth outcomeseconomic outcomeswhite paperACCPpharmacist valueClinical Pharmacy Practice
Background Information
Clinical pharmacists slash hospital deaths and costs.
Inpatient clinical pharmacists improve patient outcomes and reduce healthcare costs. Studies show reduced mortality, adverse drug events, and rehospitalization with pharmacist integration. Positioning pharmacists on interdisciplinary teams leads to economic, clinical, and humanistic benefits, yet widespread implementation is lacking. Clinical pharmacists are integral to enhancing patient care and reducing costs in inpatient settings.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Citation:Dumont Z, Rogers KC, Alhammad AM, et al. Value of Inpatient Clinical Pharmacists. Journal of the American College of Clinical Pharmacy : JACCP. 2026;9(6):e70230. doi:10.1002/jac5.70230
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.